Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating MK-2870 alone or with other therapies for gastrointestinal cancers is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers [Phase 1]
Phase 1 trial evaluating a WT1-targeted immunotherapy in HLA-A*0201+ WT1+ recurrent/metastatic cancers has completed, including colorectal c…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial [Phase 1, Phase 2]
Clinical STOPTRAFFIC-1 trial evaluates SX-682 in combination with Nivolumab for RAS-mutated, MSS unresectable or metastatic colorectal cance…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Liquid Biopsy in Early Colorectal Lesions
A clinical trial investigating liquid biopsy biomarkers for early detection of colorectal lesions; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer [Phase 3]
This is a Phase Ib/III trial update for suvemcitug in combination with trifluridine/tipiracil for refractory metastatic colorectal cancer; t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2026-01-22Clinical Trial Update: Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases [Phase 2]
Phase 2 trial evaluating Ivonescimab in combination with chemotherapy for metastatic colorectal cancer without liver metastases; the study i…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Comparison of Laparoscopic and Open Total Mesocolic Excision With Central Vascular Ligation for Right Colon Carcinoma [NA]
This clinical trial compares laparoscopic and open total mesocolic excision with central vascular ligation for right colon carcinoma. The st…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection [Phase 3]
Phase 3 trial update evaluating TAS-102 (trifluridine/tipiracil) for preventing latent metastasis identified via circulating tumor DNA in co…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients [NA]
This clinical trial update describes a self-monitoring platform to track medication safety concerns in cancer patients, sponsored by the Uni…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating olanzapine for cancer-associated appetite loss in patients with advanced esophageal, gastric, colorec…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 study evaluating DKY709 alone or in combination with PDR001 in patients with advanced solid tumors. The enrolled diseases include …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cabozantinib plus durvalumab with or without tremelimumab in patients with gastroesophageal cancer and o…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Faecal Immunochemical Tests (FIT) for Surveillance After Colorectal Cancer (CRC) Study
This clinical trial is evaluating the use of Faecal Immunochemical Tests (FIT) for surveillance after colorectal cancer. Recruitment is ongo…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: EXoPERT EMERALD Clinical Study
Clinical trial update indicates the EXoPERT EMERALD study is currently recruiting across multiple cancer indications, including breast, colo…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study [NA]
This clinical trial update describes the THRIVE study, which investigates home-based exercise strategies for underserved minority cancer pat…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: MA-CRC-II-016 SHR-1811 [Phase 2]
Phase 2 clinical trial update for SHR-1811 (MA-CRC-II-016) in metastatic colorectal cancer with HER2. The study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer [NA]
This Boehringer Ingelheim-sponsored trial compares tissue and liquid biopsies across multiple cancers—non-small cell lung cancer, colorectal…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis [Phase 2]
Phase 2 clinical trial sponsored by Northwestern University is evaluating atorvastatin for reducing colorectal cancer risk in longstanding u…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer [Phase 2]
A Phase 2 clinical trial update comparing Fruquintinib plus trifluridine/tipiracil versus Bevacizumab plus trifluridine/tipiracil in advance…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Phase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unresectable Liver-Metastatic pMMR/MSS Colorectal Cancer: Safety, Tolerability, and Efficacy. [Phase 2]
A Phase Ib/II trial evaluates QL1706 plus Fruquintinib with SCRT versus standard third-line therapy in unresectable liver-metastatic pMMR/MS…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer [Phase 2]
This Phase 2 trial of regorafenib in combination with pembrolizumab for MSI-H colorectal cancer was terminated.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: What Influence Re-participation in the Danish Colorectal Screening Program.
This clinical trial update discusses factors influencing re-participation in the Danish colorectal cancer screening program; the study is cu…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Colonoscopy Bowel Prep Comparison Among Diabetic Patients [Phase 4]
Phase 4 clinical trial update comparing bowel preparation regimens for colonoscopy in diabetic patients. The study is currently recruiting f…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway
A clinical trial update for the COCO program (Colorectal Omics and ofCS Proteoglycans) focused on colorectal cancer screening and diagnostic…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A prospective observational validation of a cfDNA assay for early cancer detection and minimal residual disease is currently recruiting acro…